Microbiome Analysis

A healthy microbiome is vital because high or low microbial diversity can have different implications for health or disease, depending on the body site. Pharma is harnessing the microbiome to potentially treat auto-immune, metabolic and infectious diseases. Pipeline microbiome therapeutics show promise, but must also overcome hurdles, as it is currently unknown how the microbiome affects human health.

Our series of Microbiome Analysis reports will help you make better and more informed decisions.

Download the guide to our Microbiome Analysis report series here.

I consent to GlobalData collecting my details provided via this form.

You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our GlobalData Privacy Policy to see how we protect and manage your submitted data.